SEC-sourced researchBeta
BEAM
Beam Therapeutics Inc.
Company comparison ↗
Data passport
- CIK
- 0001745999
- Exchange
- Nasdaq
- Business activity
- — · SIC 2836
- Financial inputs
- 6/6
- Filing date
- Oct 2, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2023 | 377,709,000.0000 | Feb 24, 2026 |
| December 2024 | 63,518,000.0000 | Feb 24, 2026 |
| December 2025 | 139,743,000.0000 | Feb 24, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 139,743,000.0000 | -79,992,000.0000 | -345,102,000.0000 | 1,481,177,000.0000 | 242,819,000.0000 | Feb 24, 2026 |
| December 2024 | 63,518,000.0000 | -376,742,000.0000 | -347,246,000.0000 | 1,103,824,000.0000 | 370,279,000.0000 | Feb 24, 2026 |
| December 2023 | 377,709,000.0000 | -132,527,000.0000 | -149,195,000.0000 | — | — | Feb 24, 2026 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $139.74M | December 2025 | Feb 24, 2026 | 10-K |
| Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax | $63.52M | December 2024 | Feb 24, 2026 | 10-K |
| Net incomeNetIncomeLoss | -$79.99M | December 2025 | Feb 24, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | -$345.1M | December 2025 | Feb 24, 2026 | 10-K |
| Total assetsAssets | $1.48B | December 2025 | Feb 24, 2026 | 10-K |
| Total liabilitiesLiabilities | $242.82M | December 2025 | Feb 24, 2026 | 10-K |